(1)
Krasiuk Е.; Grigorieva Є.; Semeryk Ю. CONTROL OF SECONDARY HYPERPARATIREOSIS BY INTRAVENOUS INTRODUCTION OF PARSABIV IN PATIENTS WITH CHRONIC KIDNEY DISEASE V D STAGE IN HEMODIALYSIS. APN 2021, 51-57.